ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Inventiva

Inventiva (IVA)

2,17
-0,01
( -0,46% )
Mis à jour : 16:42:07

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
2,17
Prix Achat
2,17
Prix Vente
2,18
Volume échangé
10 941
2,17 Fourchette du Jour 2,20
1,434 Plage de 52 semaines 4,44
Cap du marché
Clôture Veille
2,18
Ouverture
2,18
Dernière Transaction
2
@
2.17
Dernière heure de transaction
16:57:02
Volume financier
-
VWAP
-
Volume moyen (3 m)
54 355
Actions en circulation
210 670 845
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-4,14
Bénéfice par action (BPA)
-0,52
Chiffre d'affairess
23,16M
Bénéfice net
-110,43M

À propos de Inventiva

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Daix, Fra
Fondé
-
Inventiva est coté dans le secteur Biological Pds,ex Diagnstics de la Euronext avec le ticker IVA. Le dernier cours de clôture d'Inventiva était de 2,18 €. Au cours de la dernière année, les actions de Inventiva ont été négociées dans une fourchette de prix de 1,434 € à 4,44 €.

Inventiva compte actuellement 210 670 845 actions en circulation. La capitalisation boursière d'Inventiva est de 459,26 € million. Inventiva a un ratio cours/bénéfice (ratio PE) de -4.14.

IVA Dernières nouvelles

Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference »

Inventiva annonce sa participation à la « 43rd Annual J.P. Morgan Healthcare Conference » Daix (France), New York City (New York, Etats Unis), le 17 décembre 2024 – Inventiva (Euronext Paris and...

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA...

Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference

Daix (France), New York City (New York, United States), December 17, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million Inventiva secures €21.4 million leading to completion of...

Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant maximum de 348 millions d'euros

Inventiva obtient 21,4 millions d'euros complétant la première tranche du financement multi-tranches annoncé précédemment d'un montant maximum de 348 millions d'euros Inventiva lève...

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million

Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on...

Résultats des votes de l’Assemblée Générale Mixte des actionnaires – 11 décembre 2024

Résultats des votes de l’Assemblée Générale Mixte des actionnaires – 11 décembre 2024 Daix (France), New York City (New York, Etats-Unis), le 11 décembre 2024 – Inventiva (Euronext Paris et Nasdaq...

Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024

Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024 Daix (France), New York City (New York, United States), December 11, 2024 – Inventiva (Euronext Paris and...

Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024

Daix (France), New York City (New York, United States), December 11, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...

Inventiva publie ses informations financières du 3ème trimestre 2024¹

Inventiva publie ses informations financières du 3ème trimestre 2024¹ Trésorerie et équivalents de trésorerie à 13,9 millions d’euros au 30 septembre 2023.Chiffre d’affaires de 1,3 millions...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.06-2.690582959642.232.282.1783892.20147693DE
4-0.36-14.22924901192.532.532214052.27710137DE
120.6139.10256410261.563.21.434543552.40814853DE
26-0.53-19.62962962962.73.21.434421972.30964245DE
52-1.93-47.07317073174.14.441.434479522.90346897DE
156-9.73-81.764705882411.912.181.434544683.81943707DE
260-1.31-37.64367816093.4816.161.434643557.06412391DE

IVA - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?
The current share price of Inventiva is 2,17 €
How many Inventiva shares are in issue?
Inventiva has 210 670 845 shares in issue
What is the market cap of Inventiva?
The market capitalisation of Inventiva is EUR 459,26M
What is the 1 year trading range for Inventiva share price?
Inventiva has traded in the range of 1,434 € to 4,44 € during the past year
What is the PE ratio of Inventiva?
The price to earnings ratio of Inventiva is -4,14
What is the cash to sales ratio of Inventiva?
The cash to sales ratio of Inventiva is 19,75
What is the reporting currency for Inventiva?
Inventiva reports financial results in EUR
What is the latest annual turnover for Inventiva?
The latest annual turnover of Inventiva is EUR 23,16M
What is the latest annual profit for Inventiva?
The latest annual profit of Inventiva is EUR -110,43M
What is the registered address of Inventiva?
The registered address for Inventiva is 50 RUE DE DIJON, DAIX, 21121
What is the Inventiva website address?
The website address for Inventiva is www.inventivapharma.com
Which industry sector does Inventiva operate in?
Inventiva operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ALENREntreprendre
8,05 €
(54,81%)
91
MLOCTOctopus Biosafety
0,182 €
(45,60%)
34,73k
MLWEYWeya
0,0185 €
(37,04%)
1 000
NACONNacon SA
0,74 €
(22,92%)
810,85k
CANDCandela Invest
1,46 €
(21,67%)
308
EIFDSTour Eiffel DS
0,012 €
(-34,78%)
53,63k
MLFTIFrance Tourisme Immobilier
0,028 €
(-21,13%)
3,44k
PROACProactis SA
0,0525 €
(-20,45%)
5k
ALTROTronic s Microsystems
4,02 €
(-19,60%)
28
SEQUASequana medical NV
3,34 €
(-13,70%)
1,49M
ATOAtos SE
0,0027 €
(0,00%)
2,25B
ALCYBCybergun
0,0001 €
(0,00%)
45,92M
BCPBanco Comercial Portugues SA
0,4645 €
(0,93%)
38,52M
ALHPIHopium SA
0,0046 €
(-8,00%)
17,83M
BIOSBiosenic
0,0055 €
(-5,17%)
7,97M
Aucune Discussion Trouvée
Ajouter une Discussion